Literature DB >> 33489598

Concurrent Scleredema and Pyoderma Gangrenosum: Case Report and Review of Comorbid Conditions.

Joanne S Jacob1, Philip R Cohen2.   

Abstract

Scleredema is a connective tissue disorder that presents as diffuse induration of skin, most often involving the upper body. Scleredema can be associated with prior infection, monoclonal gammopathy, and diabetes mellitus. Pyoderma gangrenosum is a neutrophilic dermatosis that presents as an ulcer with violaceous borders. Pyoderma gangrenosum can be idiopathic or associated with various conditions. A 66-year-old man with a 20-year history of scleredema diabeticorum presented with idiopathic pyoderma gangrenosum in the affected area of scleredema on his neck. His pyoderma gangrenosum resolved after treatment with topical and intralesional corticosteroids. Diseases associated with scleredema, pyoderma gangrenosum or both are reviewed.
Copyright © 2020, Jacob et al.

Entities:  

Keywords:  arthritis; bowel; diabetes; disease; gammopathy; gangrenosum; inflammatory; myeloma; pyoderma; scleredema

Year:  2020        PMID: 33489598      PMCID: PMC7815298          DOI: 10.7759/cureus.12188

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  20 in total

1.  Improvement in clinical symptoms of scleredema diabeticorum by frequency-modulated electromagnetic neural stimulation: a case report.

Authors:  Alessandra Gandolfi; Andrea Pontara; Gaetano Di Terlizzi; Nathalie Rizzo; Roberto Nicoletti; Marina Scavini; Gabriella Galimberti; Emanuele Bosi
Journal:  Diabetes Care       Date:  2014-11       Impact factor: 19.112

2.  PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens.

Authors:  J Gottlieb; M Madrange; C Gardair; E Sbidian; A Frazier; P Wolkenstein; G Hickman; P Schneider; C Baudry; P Claudepierre; P Bertheau; P Richette; A Smahi; H Bachelez
Journal:  Br J Dermatol       Date:  2019-07-25       Impact factor: 9.302

Review 3.  Treatment of Scleroedema Adultorum Buschke: A Systematic Review.

Authors:  Diana Miguel; Sibylle Schliemann; Peter Elsner
Journal:  Acta Derm Venereol       Date:  2018-03-13       Impact factor: 4.437

Review 4.  Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.

Authors:  Khalaf Kridin; Arnon D Cohen; Kyle T Amber
Journal:  Am J Clin Dermatol       Date:  2018-08       Impact factor: 7.403

5.  The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

Authors:  Hovik J Ashchyan; Daniel C Butler; Caroline A Nelson; Megan H Noe; William G Tsiaras; Stephen J Lockwood; William D James; Robert G Micheletti; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

6.  Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients.

Authors:  F Rongioletti; F Kaiser; E Cinotti; D Metze; M Battistella; P G Calzavara-Pinton; K Damevska; G Girolomoni; J André; J-L Perrot; W Kempf; B Cavelier-Balloy
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-08-24       Impact factor: 6.166

Review 7.  Pyoderma gangrenosum: an updated review.

Authors:  E Ruocco; S Sangiuliano; A G Gravina; A Miranda; G Nicoletti
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-03-11       Impact factor: 6.166

8.  Scleredema associated with Sjögren's syndrome.

Authors:  João Alves; Tiago Judas; Tiago Ferreira; Diogo Matos; Elvira Bártolo
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

9.  Perineal pyoderma gangrenosum in pregnancy: A case report.

Authors:  Takako Ohmaru-Nakanishi; Haruka Goto; Miyako Maehara; Hiroko Oishi; Yosuke Ueoka
Journal:  Case Rep Womens Health       Date:  2019-03-07

Review 10.  Scleredema associated with immunoglobulin A-κ smoldering myeloma: a case report and review of the literature.

Authors:  B S D P Keragala; H M M T B Herath; G H D C Janappriya; B S Dissanayaka; S C Shyamini; D P Liyanagama; Thanushah Balendran; S R Constantine; C N Gunasekera
Journal:  J Med Case Rep       Date:  2019-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.